Short-term and midterm results of a North American multicenter study of the Ross procedure in patients older and younger than 50 years of age

一项北美多中心研究对50岁以上和50岁以下患者进行Ross手术的短期和中期结果

阅读:1

Abstract

OBJECTIVE: To compare outcomes of the Ross procedure in patients older than and younger than 50 years of age. METHODS: This is a review of patients who underwent a Ross procedure at a participating site in the North American Ross Consortium. Data were analyzed for differences in short- and medium-term outcomes. RESULTS: Total cohort size was 477 patients, with n = 350 <50 years old and n = 127 ≥50 years. The median age of the entire cohort was 41 years; 37 in the <50 years cohort and 54 in the ≥50 years cohort (P < .001). Patients in the <50 years cohort had lower body mass index (26.9 vs 28.7, P = .001) and had lower rates of preoperative hypertension (28% vs 52%, P < .0001). Perioperative outcomes were similar between groups. There was a greater rate of postoperative atrial fibrillation/flutter (24% vs 9.25%, P < .001) and stroke (3.97% vs 0%, P = .002) in the ≥50 years cohort; however, in-hospital mortality was 0.63% in the entire cohort and was similar between groups (≥50 years= 1.59%, <50 years = 0.29%, P = .174). Freedom from valve-related reintervention was 84% over the first decade and did not differ between cohorts. Overall survival at 60-months demonstrated improved survival in the <50 years cohort (97% vs 94%, P < .001); however, was overall excellent at 96%. CONCLUSIONS: The Ross procedure can be safely performed in patients older than 50 years in select centers. There is a greater risk of stroke and postoperative atrial fibrillation/flutter in older patients; however, perioperative survival is similar.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。